×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
上海药物研究所 [14]
内容类型
期刊论文 [14]
发表日期
2021 [1]
2020 [1]
2019 [1]
2018 [2]
2016 [2]
2015 [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共14条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
发表日期升序
发表日期降序
提交时间升序
提交时间降序
题名升序
题名降序
作者升序
作者降序
Discovery of novel ketoxime ether derivatives with potent FXR agonistic activity, oral effectiveness and high liver/blood ratio
期刊论文
BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 卷号: 43, 页码: 13
作者:
Tang, Xuehang
;
Ning, Mengmeng
;
Ye, Yangliang
;
Gu, Yipei
;
Yan, Hongyi
收藏
  |  
浏览/下载:49/0
  |  
提交时间:2021/11/04
FXR agonist
Ketoxime ether
Target genes
Liver
blood ratio
Systemic activation
Design of G-protein-coupled bile acid receptor 1 (GPBAR1, TGR5) soft drugs with reduced gallbladder-filling effects
期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 卷号: 203, 页码: 12
作者:
Han, Fanghui
;
Ning, Mengmeng
;
Cao, Hua
;
Ye, Yangliang
;
Feng, Ying
收藏
  |  
浏览/下载:32/0
  |  
提交时间:2020/12/21
Soft drug
TGR5
GLP-1
Gallbladder-filling effects
Rapid metabolism
Carboxylic ester
TGR5 agonist ameliorates insulin resistance in skeletal muscles and improves glucose homeostasis in diabetic mice
期刊论文
METABOLISM-CLINICAL AND EXPERIMENTAL, 2019, 卷号: 99, 页码: 45-56
作者:
Huang, Suling
;
Ma, Shanyao
;
Ning, Mengmeng
;
Yang, Wenji
;
Ye, Yangliang
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2020/07/01
TGR5
Glucose homeostasis
Insulin resistance
Skeletal muscle
Type 2 diabetes
Design, synthesis and structure activity relationship studies of GPR40 agonists containing amide linker
期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 152, 页码: 175-194
作者:
Chen, Tingting
;
Ning, Mengmeng
;
Ye, Yangliang
;
Wang, Kai
;
Leng, Ying
收藏
  |  
浏览/下载:30/0
  |  
提交时间:2019/01/08
GPR40
FFAR1
Insulin secretion
Type 2 diabetes mellitus
CNS
Linderane Suppresses Hepatic Gluconeogenesis by Inhibiting the cAMP/PKA/CREB Pathway Through Indirect Activation of PDE 3 via ERK/STAT3
期刊论文
FRONTIERS IN PHARMACOLOGY, 2018, 卷号: 9
作者:
Xie, Wei
;
Ye, Yangliang
;
Feng, Ying
;
Xu, Tifei
;
Huang, Suling
收藏
  |  
浏览/下载:42/0
  |  
提交时间:2019/01/08
cAMP
gluconeogenesis
linderane
phosphodiesterase
type 2 diabetes
Discovery and Structure-Activity Relationship Study of 4-Phenoxythiazol-5-carboxamides as Highly Potent TGR5 Agonists
期刊论文
CHEMICAL & PHARMACEUTICAL BULLETIN, 2016, 卷号: 64, 期号: 4, 页码: 326-339
作者:
Chen, Zhixiang
;
Ning, Mengmeng
;
Zou, Qingan
;
Cao, Hua
;
Ye, Yangliang
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2019/01/08
Takeda G-protein-coupled receptor 5 agonist
bioisostere
microsomal clearance
structure-activity relationship
ol3anovellowabsorbedtgr5agonistwithreducedsideeffectsloweredbloodglucoseviadualactionsontgr5activationanddpp4inhibition
期刊论文
actapharmacologicasinica, 2016, 卷号: 000, 期号: 010, 页码: 1359
作者:
Ma Shanyao
;
Ning Mengmeng
;
Zou Qingan
;
Feng Ying
;
Ye Yangliang
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2020/07/01
OL3
MN6
linagliptin
TGR5 agonist
DPP4 inhibitor
GLP-1
low-absorbed
gallbladder filling
type 2 diabetes mellitus
Discovery of Intestinal Targeted TGR5 Agonists for the Treatment of Type 2 Diabetes
期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 卷号: 58, 期号: 8, 页码: 3315-3328
作者:
Duan, Hongliang
;
Ning, Mengmeng
;
Zou, Qingan
;
Ye, Yangliang
;
Feng, Ying
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2019/01/08
Design, Synthesis, and Structure-Activity Relationships of 3,4,5-Trisubstituted 4,5-Dihydro-1,2,4-oxadiazoles as TGR5 Agonists
期刊论文
CHEMMEDCHEM, 2013, 卷号: 8, 期号: 7, 页码: 1210-1223
作者:
Zhu, Junjie
;
Ye, Yangliang
;
Ning, Mengmeng
;
Mandi, Attila
;
Feng, Ying
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2019/01/08
4
5-dihydro-1
2
4-oxadiazoles
cycloaddition
metabolic disorders
structure-activity relationships
TGR5
Pyrimidinyl-arylpropionic acid derivatives: viable resources in the development of new antineoplastic agents
期刊论文
INVESTIGATIONAL NEW DRUGS, 2010, 卷号: 28, 期号: 4, 页码: 472-481
作者:
Xiong, Xishan
;
Wang, Li
;
Ye, Yangliang
;
Fu, Lili
;
Chen, Minli
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2019/01/08
Peroxisome proliferator-activated receptor gamma
alpha-aryloxy-alpha-methylhydrocinnamic acid derivative
IC50
Cell cycle
Tumor
©版权所有 ©2017 CSpace - Powered by
CSpace